Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

248.13
Delayed Data
As of 3:55pm ET
 +22.59 / +10.02%
Today’s Change
128.50
Today|||52-Week Range
484.99
+59.06%
Year-to-Date

Today’s Trading

Previous close225.54
Today’s open226.20
Day’s range225.10 - 249.98
Volume795,079
Average volume (3 months)544,964
Market cap$5.1B
Dividend yield--
Data as of 3:55pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)+48.91%
Earnings growth (this year)-275.76%
Earnings growth (next 5 years)-6.30%
Revenue growth (last year)-33.71%
P/E ratioNM
Price/Sales759.12
Price/Book53.07

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-0.84-2.33%
AKRXAkorn Inc-4.45-8.29%
GRFSGrifols SA+0.16+0.50%
RCPTReceptos Inc-1.84-1.45%
Data as of 3:55pm ET, 03/03/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$1.68
Annual revenue (last year)$1.6M
Annual profit (last year)-$67.8M
Net profit margin-4,180.52%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account